Vivimed Labs Ltd (VIVIMEDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 612893,
    "name": "Vivimed Labs.",
    "stock_name": "Vivimed Labs.",
    "full_name": "Vivimed Labs Ltd",
    "name_url": "stocks-analysis/vivimed-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.22",
    "chg": -0.37,
    "chgp": "-4.87%",
    "dir": -1,
    "prev_price": "7.59",
    "mcapval": "61.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532660,
    "symbol": "VIVIMEDLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE526G01021",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "2.73 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivimed-labs-612893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivimed Labs Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3824264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_stocks_hitting_lower_circuit_3824264.png",
        "date": "2026-02-06 11:00:11",
        "description": "Vivimed Labs Ltd witnessed a sharp decline on 6 Feb 2026, hitting its lower circuit limit of 4.88% as intense selling pressure gripped the stock. The micro-cap pharmaceutical company’s shares closed at ₹7.21, marking a maximum daily loss and continuing a troubling downtrend amid falling investor participation and unfilled supply."
      },
      {
        "title": "Vivimed Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivimed-labs-ltd-is-rated-strong-sell-3824062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_mojoScore_3824062.png",
        "date": "2026-02-06 10:10:50",
        "description": "Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vivimed Labs Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3822053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_stocks_hitting_lower_circuit_3822053.png",
        "date": "2026-02-05 10:00:15",
        "description": "Vivimed Labs Ltd witnessed a sharp decline on 5 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹7.58. The stock faced intense selling pressure, marking its fourth consecutive day of losses and underperforming both its sector and the broader market indices."
      },
      {
        "title": "Vivimed Labs Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3820151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_stocks_hitting_lower_circuit_3820151.png",
        "date": "2026-02-04 10:00:20",
        "description": "Vivimed Labs Ltd witnessed intense selling pressure on 4 Feb 2026, hitting its lower circuit limit of ₹7.97, marking a maximum daily loss of 4.89%. The stock’s sharp decline reflects mounting investor concerns amid sustained negative momentum and dwindling participation."
      },
      {
        "title": "When is the next results date for Vivimed Labs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vivimed-labs-ltd-3819248",
        "imagepath": "",
        "date": "2026-02-03 23:18:12",
        "description": "The next results date for Vivimed Labs Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Vivimed Labs Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3818007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_stocks_hitting_lower_circuit_3818007.png",
        "date": "2026-02-03 10:00:26",
        "description": "Vivimed Labs Ltd witnessed a sharp decline on 3 Feb 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The share price plunged by 4.99% to close at ₹8.38, marking a maximum daily loss and signalling panic selling among investors amid subdued market sentiment."
      },
      {
        "title": "Vivimed Labs Ltd Surges to Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3814441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VivimedLabsLtd_stocks_hitting_upper_circuit_3814441.png",
        "date": "2026-02-01 11:00:23",
        "description": "Vivimed Labs Ltd witnessed a robust rally on 1 Feb 2026, hitting its upper circuit limit of 9.28, marking a maximum daily gain of 4.98%. This surge was driven by intense buying interest, resulting in a regulatory freeze on further trading and leaving a significant portion of demand unfilled."
      },
      {
        "title": "Vivimed Labs Ltd Surges to Upper Circuit on Robust Buying Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-surges-to-upper-circuit-on-robust-buying-momentum-3810930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VivimedLabsLtd_stocks_hitting_upper_circuit_3810930.png",
        "date": "2026-01-30 10:00:30",
        "description": "Vivimed Labs Ltd surged to its upper circuit limit on 30 Jan 2026, registering a maximum daily gain of 4.99% as strong buying interest propelled the stock to ₹8.84. This marks the fifth consecutive day of gains, with the stock delivering a remarkable 25.64% return over this period, significantly outperforming its sector and the broader market indices."
      },
      {
        "title": "Vivimed Labs Ltd Surges to Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-3809494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VivimedLabsLtd_stocks_hitting_upper_circuit_3809494.png",
        "date": "2026-01-29 11:00:09",
        "description": "Vivimed Labs Ltd surged to hit its upper circuit limit on 29 Jan 2026, propelled by robust buying interest and a notable 4.98% gain in a single trading session. The micro-cap pharmaceutical stock demonstrated significant investor enthusiasm despite a broader market downturn, reflecting a compelling short-term momentum that has caught the attention of traders and analysts alike."
      }
    ],
    "total": 45,
    "sid": "612893",
    "stock_news_url": "https://www.marketsmojo.com/news/vivimed-labs-612893"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
      "datetime": "06-Feb-2026",
      "details": "Resignation of CFO",
      "source": "BSE"
    },
    {
      "caption": "Updates",
      "datetime": "03-Feb-2026",
      "details": "disclosure under regulation 30",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for 31St December 2025 Results",
      "datetime": "02-Feb-2026",
      "details": "Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 31st december 2025 results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 18",
          "dt": "2018-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 06 Apr 16",
          "dt": "2016-04-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivimed Labs Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-06 11:00:11

Vivimed Labs Ltd witnessed a sharp decline on 6 Feb 2026, hitting its lower circuit limit of 4.88% as intense selling pressure gripped the stock. The micro-cap pharmaceutical company’s shares closed at ₹7.21, marking a maximum daily loss and continuing a troubling downtrend amid falling investor participation and unfilled supply.

Read full news article

Vivimed Labs Ltd is Rated Strong Sell

2026-02-06 10:10:50

Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vivimed Labs Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-05 10:00:15

Vivimed Labs Ltd witnessed a sharp decline on 5 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹7.58. The stock faced intense selling pressure, marking its fourth consecutive day of losses and underperforming both its sector and the broader market indices.

Read full news article

Vivimed Labs Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-04 10:00:20

Vivimed Labs Ltd witnessed intense selling pressure on 4 Feb 2026, hitting its lower circuit limit of ₹7.97, marking a maximum daily loss of 4.89%. The stock’s sharp decline reflects mounting investor concerns amid sustained negative momentum and dwindling participation.

Read full news article

When is the next results date for Vivimed Labs Ltd?

2026-02-03 23:18:12

The next results date for Vivimed Labs Ltd is scheduled for 13 February 2026....

Read full news article

Vivimed Labs Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-03 10:00:26

Vivimed Labs Ltd witnessed a sharp decline on 3 Feb 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The share price plunged by 4.99% to close at ₹8.38, marking a maximum daily loss and signalling panic selling among investors amid subdued market sentiment.

Read full news article

Vivimed Labs Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-02-01 11:00:23

Vivimed Labs Ltd witnessed a robust rally on 1 Feb 2026, hitting its upper circuit limit of 9.28, marking a maximum daily gain of 4.98%. This surge was driven by intense buying interest, resulting in a regulatory freeze on further trading and leaving a significant portion of demand unfilled.

Read full news article

Vivimed Labs Ltd Surges to Upper Circuit on Robust Buying Momentum

2026-01-30 10:00:30

Vivimed Labs Ltd surged to its upper circuit limit on 30 Jan 2026, registering a maximum daily gain of 4.99% as strong buying interest propelled the stock to ₹8.84. This marks the fifth consecutive day of gains, with the stock delivering a remarkable 25.64% return over this period, significantly outperforming its sector and the broader market indices.

Read full news article

Vivimed Labs Ltd Surges to Upper Circuit Amid Strong Buying Pressure

2026-01-29 11:00:09

Vivimed Labs Ltd surged to hit its upper circuit limit on 29 Jan 2026, propelled by robust buying interest and a notable 4.98% gain in a single trading session. The micro-cap pharmaceutical stock demonstrated significant investor enthusiasm despite a broader market downturn, reflecting a compelling short-term momentum that has caught the attention of traders and analysts alike.

Read full news article

View All News